Measles future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Despite the impact of primary prevention with vaccination in the incidence of measles, there is still no specific antiviral treatment for the disease, once it develops. Most developing countries are still severely affected by the incidence of this conditions, due to the absence of an adequate vaccination system. | |||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== |
Revision as of 04:28, 25 June 2014
Measles Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Measles future or investigational therapies On the Web |
American Roentgen Ray Society Images of Measles future or investigational therapies |
Risk calculators and risk factors for Measles future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Despite the impact of primary prevention with vaccination in the incidence of measles, there is still no specific antiviral treatment for the disease, once it develops. Most developing countries are still severely affected by the incidence of this conditions, due to the absence of an adequate vaccination system.